News publication
Everything we hold that sprim.com published.
Every article we hold from sprim.com.
Vaxxas announced a roughly A$90m financing — Series D equity led by SPRIM Global Investments plus debt — to advance its needle-free vaccine patch, alongside leadership changes including a new chair.
Deals recorded from sprim.com's coverage. A round is listed once, however many of their articles mention it.
Companies named in sprim.com's articles, most-covered first.
| Company | What it does | Articles |
|---|---|---|
| Coalition for Epidemic Preparedness Innovations | 1 | |
| Gates Foundation | 1 | |
| The University of Queensland | 1 | |
| US government | 1 | |
| Vaxxas | Biotech/MedTech company | 1 |
| Wellcome | 1 |
Investors named in sprim.com's articles, most-covered first.
| Investor | What it does | Articles |
|---|---|---|
| Brandon Capital-Hostplus | 1 | |
| LGT Crestone | 1 | |
| OneVentures | 1 | |
| SPRIM Global Investments | Venture arm of global life sciences firm SPRIM | 1 |